BACKGROUND: Expression of gastrin-releasing peptide receptor (GRPR) is elevated in mucosa adjacent to head and neck squamous cell carcinoma (HNSCC) compared with mucosa from cancer-free controls, suggesting elevated GRPR expression may indicate presence of HNSCC. METHODS: We measured GRPR mRNA levels in histologically normal buccal mucosa from 65 surgical patients with HNSCC and 75 cancer-free control subjects using quantitative polymerase chain reaction (PCR). We tested for association between GRPR expression and HNSCC and evaluated differences in patient progression-free survival (PFS). RESULTS: Buccal GRPR expression was higher in cases but not controls who were active smokers (p = .04). High GRPR expression was associated with HNSCC (odds ratio [OR] = 3.55; 95% confidence interval [CI] = 1.15-10.93), even after adjustment for age, sex, tobacco use, and sample storage time. PFS did not differ between patients with HNSCC with high versus low GRPR expression (p = .22). CONCLUSION: Elevated buccal GRPR expression was significantly associated with HNSCC independent of known risk factors but was not an indicator of disease prognosis.
BACKGROUND: Expression of gastrin-releasing peptide receptor (GRPR) is elevated in mucosa adjacent to head and neck squamous cell carcinoma (HNSCC) compared with mucosa from cancer-free controls, suggesting elevated GRPR expression may indicate presence of HNSCC. METHODS: We measured GRPR mRNA levels in histologically normal buccal mucosa from 65 surgical patients with HNSCC and 75 cancer-free control subjects using quantitative polymerase chain reaction (PCR). We tested for association between GRPR expression and HNSCC and evaluated differences in patient progression-free survival (PFS). RESULTS: Buccal GRPR expression was higher in cases but not controls who were active smokers (p = .04). High GRPR expression was associated with HNSCC (odds ratio [OR] = 3.55; 95% confidence interval [CI] = 1.15-10.93), even after adjustment for age, sex, tobacco use, and sample storage time. PFS did not differ between patients with HNSCC with high versus low GRPR expression (p = .22). CONCLUSION: Elevated buccal GRPR expression was significantly associated with HNSCC independent of known risk factors but was not an indicator of disease prognosis.
Authors: J M Siegfried; M A DeMichele; J D Hunt; A G Davis; K P Vohra; J M Pilewski Journal: Am J Respir Crit Care Med Date: 1997-08 Impact factor: 21.405
Authors: Y Ishikawa-Brush; J F Powell; P Bolton; A P Miller; F Francis; H F Willard; H Lehrach; A P Monaco Journal: Hum Mol Genet Date: 1997-08 Impact factor: 6.150
Authors: Neal D Freedman; Christian C Abnet; Michael F Leitzmann; Albert R Hollenbeck; Arthur Schatzkin Journal: Cancer Date: 2007-10-01 Impact factor: 6.860
Authors: Xuwan Liu; Diane L Carlisle; Michelle C Swick; Autumn Gaither-Davis; Jennifer R Grandis; Jill M Siegfried Journal: Exp Cell Res Date: 2007-02-03 Impact factor: 3.905
Authors: Annie A Suganya S; K J Kochurani; Madhumathy G Nair; Jiss Maria Louis; Santhosh Sankaran; R Rajagopal; K Santhosh Kumar; Parvin Abraham; Balagopal P G; Paul Sebastian; Thara Somananthan; Tessy Thomas Maliekal Journal: Sci Rep Date: 2016-11-09 Impact factor: 4.379